Introduction
The glomerulonephritides comprise a spectrum of inflammatory diseases specifically affecting the glomeruli (Eremina et al., 2003) . In general, glomerular inflammation is characterized by activation of various common pro-inflammatory pathways including complement activation, production of pro-inflammatory cytokines, endothelial activation and influx of circulating leukocytes (Falk et al., 2004) . As a consequence, glomerular injury and proteinuria develop.
Based on the underlying immunologic nature of glomerulonephritides, these disorders are frequently treated with glucocorticosteroids in combination with cytotoxic agents (Javaid and Quigg, 2005) . Glucocorticosteroids and cytotoxic agents, such as cyclophosphamide, are potent anti-inflammatory and immunosuppressive agents, but have their limitation with regard to toxicity and side effects (Tam, 2006; Chadban and Atkins, 2005) . Identifying more effective and less toxic treatment for glomerulonephritis still remains a major aim. One way to increase drug efficacy and decrease side effects of treatment is to selectively deliver the therapeutic entity into the diseased tissue. Endothelial cells have obtained considerable attention as targets for this purpose (Ulbrich et al., 2003; Kuldo et al., 2005; Kamps et al., 1997) . Not only are endothelial cells in direct contact with the blood stream and consequently accessible for systemically administered therapeutics, but, they also play an essential role in the pathological process associated with glomerulonephritis. The interaction of leukocytes with activated endothelial cells is well orchestrated via processes of tethering and rolling, mediated by endothelial expression of P-and E-selectin, followed by firm adhesion through interaction between integrins of the leukocytes, This article has not been copyedited and formatted. The final version may differ from this version. 
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5 and endothelial members of the immunoglobulin superfamily, including VCAM-1 and ICAM-1 (Vestweber, 2002) .
Liposomes are high capacity drug carriers that, when modified with monoclonal antibodies, can be targeted to a selective target epitope of choice (Spragg et al., 1997; Kamps and Molema, 2006) . Inflammation related cell adhesion molecules, including E-selectin and VCAM-1, are attractive candidates as target epitopes on activated endothelium because of their increased expression during inflammation and their predominant endothelial location.
The current study was designed to explore the feasibility of local immunoliposomal delivery of the glucocorticosteroid dexamethasone into activated glomerular endothelium in glomerulonephritis.
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Material and Methods
Preparation of Iimmunoliposomes
Synthesis of immunoliposomes was as described earlier (Bartsch et al., 2005; Kamps et al., 1996) . In short, lipids from stock solutions of 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), cholesterol, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]-maleimide (DSPE-PEG-Mal) in chloroform : methanol (9 : 1), were mixed in a molar ratio of 55 : 40 : 4 : 1, dried under reduced nitrogen pressure, dissolved in cyclohexane, and lyophilized. The lipids were then hydrated in HN buffer (10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes), 135 mM NaCl, pH 6.7) or when appropriate in an aqueous solution of 75-100 mg/ml dexamethasone disodium phosphate. The liposomes formed were sized by repeated extrusion (13 times) through polycarbonate filters (Costar, Cambridge MA, USA), pore size 50 nm, using a high pressure extruder (Lipex, Vancouver, Canada). The monoclonal rat antimouse E-selectin antibody, (MES-1, kindly provided by Dr. D. Brown, Celltech group, UK) and irrelevant rat IgG (Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands) were thiolated by means of N-succinimidyl-S-acetylthioacetate, and coupled to a maleimide group at the distal end of the polyethylene glycol chain (PEG) by a sulfhydryl-maleimide coupling technique. The immunoliposomes were characterized by determining protein content, using mouse IgG as a standard (Peterson, 1977) , and phospholipid phosphorus content (Bottcher et al., 1961) . Total liposomal lipid concentrations were adjusted for the amount of cholesterol present in the liposome preparations. Per mol lipid 52.1 ± 25.6 g anti E-selectin antibody and 53.6 ± 23.1 g irrelevant rat IgG was coupled, respectively. Particle size was analyzed This article has not been copyedited and formatted. The final version may differ from this version. The content of encapsulated dexamethasone disodium-phosphate (Bufa, Hilversum,
The Netherlands) was determined after Bligh and Dyer extraction in the resulting methanol/H 2 O phase by HPLC (Melgert et al., 2000) . Per µmol lipid 55.4 ± 6.5 µg dexamethasone was encapsulated.
Animals
C57bl/6 female mice were purchased from Harlan (Zeist, The Netherlands). Animals were maintained on mouse chow and tap water ad libitum in a temperature-controlled chamber at 24°C with a 12-hr light/dark cycle. All animal experiments were performed upon approval of the local Animal Care and Use Committee of Groningen University. After an adaptation period of one week, mice were allocated to the experiments as described below.
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Induction of Accelerated Anti-GBM Glomerulonephritis
The IgG fraction was isolated from polyclonal sheep anti-mouse GBM serum by HiTrap Sephadex-Protein G column (GE Healthcare Europe GmbH, Diegem, Belgium). Induction of anti-GBM glomerulonephritis was modified from the earlier described protocol (Assmann et al., 1985; Heeringa et al., 2000) . In short, immunization was initiated by 100 µl (2 mg/ml) commercially available sheep IgG (Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands) mixed with 100 µl complete The total volume injected was 200 µl. Mice were sacrificed at 2 h (n=12), 24 h (n=6), 48 h (n=9), 7 days (n=5) and 14 days (n=11). Organs were perfused with ice-cold phosphate buffered saline (PBS) and harvested. One kidney was fixed in 4%
formaldehyde/PBS and embedded in paraffin for morphological analysis, the other kidney, and liver, spleen and heart were snap-frozen in liquid nitrogen and stored at -80°C.
Glomerulonephritis Development and Disease Progression
Five-µm cryosections were fixed in acetone for 10 minutes and incubated with fluorescein isothiocyanate (FITC)-labeled rabbit anti-sheep IgG or -anti-mouse IgG antibodies (DAKO, Glostrup, Denmark). Nuclear counterstaining was performed with 4',6-diamidino-2-phenylindole (DAPI; Boehringer, Mannheim, Germany). Sections were examined using a fluorescence microscope (DM RXA, Leica, Cambridge, UK) and Leica Q600 Qwin V01.06 software.
This article has not been copyedited and formatted. The final version may differ from this version. and urinary creatinine levels were measured by enzymatic colorimetric method using
Creatinine plus (Roche, Woerden, The Netherlands), which allows precise and specific quantification of creatinine (Keppler et al., 2007) . The creatinine clearance (C Cr ) was calculated according to the formula C Cr = [Cr urine ] x V olume urine (ml per min)
Quantitative Gene Expression Analysis by Realtime RT-PCR
Total RNA was isolated from ten 8-µm cryosections with RNeasy mini kit (Qiagen Benelux B.V., Venlo, The Netherlands) including a DNase treatment on the column. 
Immunohistochemical Analysis of Cell Adhesion Molecules, Immune Cell Infiltrates and Localization of Immunoliposomes
Five-µm cryosections were fixed in acetone for 10 min and incubated for 45 min with primary rat anti-mouse monoclonal antibodies: anti-E-selectin (MES-1), anti-VCAM-1 (clone M/K-2.7; ATCC, Manassas VA, USA) anti-neutrophil (NIMP-R14) and antimonocyte/macrophage (FA-11). Endogenous biotin was blocked by Biotin Blocking System (Dako) and peroxidase activity was blocked by incubation with 0.1% H 2 O 2 in PBS for 10 min. Subsequently, sections were incubated for 1 h with biotin labeled rabbit anti-rat antibodies (DAKO; dilution 1:300 in PBS) in the presence of 5% normal mouse serum and 5% normal sheep serum, and incubated for 30 min with Streptavidine-ABComplex-HRP (DAKO). Peroxidase activity was detected with 3-amino-9-ethylcarbazole (AEC; Sigma-Aldrich Chemie) and sections were counterstained with Mayer's hematoxylin (Klinipath, Duiven, The Netherlands).
Isotype matched controls were carried out for all primary antibodies and consistently found to be devoid of staining. Immunostaining of E-selectin in glomeruli was quantified by counting the number of glomerular cross sections expressing E-selectin.
Glomerular infiltrates were evaluated by counting the number of stained cells in
Statistic Analysis
Results
Induction and Development of Glomerulonephritis
Injection of heterologous antibodies directed against GBM resulted in onset of glomerulonephritis in mice preimmunized with non-specific sheep antibodies. We adapted the classical accelerated anti-GBM glomerulonephritis model (Assmann et al., 1985) by including TNFα in the anti-GBM antibody injection. This resulted in fast, reproducible and progressive inflammation in the glomeruli, whereas TNFα or anti-GBM antibodies alone did not result in significant leukocyte influx or glomerular injury (data not shown). Figure 1 demonstrates the development of progressive glomerulonephritis in our model at different time points from 2h to 2 weeks.
Glomerular depositions of sheep and mouse immunoglobulin were observed at all time points (Fig. 1a) with formation of glomerular intracapillary PAS-positive thrombus starting at 2 days (Fig. 1b,c) . Additionally, mild extracapillary proliferation and intratubular protein casts were noted, all indicative of glomerulonephritis induction (Fig. 1b) . Glomerular accumulations of PAS-positive material was highest at 2 days and remained present for 14 days (Fig. 1c) . Crescent formation was detected at 7 and 14 days after disease induction (Fig. 1b,d ). Two hrs after glomerulonephritis induction, a peak of intraglomerular neutrophils was observed (Fig. 1e) . The glomerular accumulation of neutrophils subsequently decreased in time, which was paralleled by an increase of intraglomerular monocytes (Fig. 1e) , a time dependent pattern that is characteristic for the experimental anti-GBM glomerulonephritis model (Assmann et al., 1985; Masaki et al., 2003) . Albuminuria was markedly increased after induction of glomerulonephritis to > 50 mg per 24h at day 7 and 14, while untreated mice secreted less than 0.1 mg albumin per 24 h (Fig. 1f) . At the same time glomerular filtration function deteriorated (Fig. 1g ).
This article has not been copyedited and formatted. The final version may differ from this version. To further examine the disease process, expression of proinflammatory genes was analyzed by quantitative RT-PCR. First, treshold values (C t ) in kidneys of untreated mice were determined. Expression of cytokines and P-and E-selectin was low whereas VCAM-1, ICAM-1 and TGFβ were moderately expressed in healthy kidneys (Table 2) . A rapid upregulation of cell adhesion molecules and cytokines was observed 2h after onset of glomerulonephritis (Fig. 2) . The expression of cell adhesion molecules and cytokines was significantly higher compared to untreated animals throughout the experiment. Expression of the fibrosis related TGFβ enhanced slightly in time, indicative of ongoing glomerular injury and crescent formation (Border and Noble, 1994) .
To characterize the proinflammatory gene expression profile specifically in glomeruli at the early stages of disease, we analyzed laser microdissected glomeruli.
Interestingly, a spatial and temporal heterogenic regulation of proinflammatory genes in response to disease induction was observed. E-selectin was preferentially upregulated in glomeruli at all time points (Fig. 3a) . Initially P-selectin was more abundantly expressed in the glomeruli than in total kidney isolates, whereas upregulation of VCAM-1 was more pronounced in the non-glomerular vascular compartments at all time points. Similarly to VCAM-1, glomerulonephritis induced expression of MCP1 was predominantly located outside the glomeruli (Fig. 3a) .
Gene expression data were corroborated by immunohistochemical analysis for Eselectin and VCAM-1 (Fig. 3b ). E-selectin protein was solely produced in glomeruli whereas VCAM-1 was present in glomerular capillaries and in microvascular beds outside the glomeruli. The immunostaining of VCAM-1 was weak in glomeruli and stronger in arterioles. While E-selectin protein was undetectable in untreated mice, 2 h after disease induction 75 ± 5 % of all glomeruli were E-selectin positive. After 2
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I.V. Administered Ab Esel -liposomes Selectively Homed to Hlomeruli
The disease specific glomerular expression of E-selectin provided it a promising target molecule on glomerular endothelial cells. Immunohistochemical staining demonstrated selective homing of i.v. administered immunoliposomes containing monoclonal anti-E-selectin antibodies (Ab Esel ) to the diseased glomeruli (Fig 4a) . No staining was observed elsewhere in the kidney. This localization remained during disease development, although in time the staining became less pronounced.
Glomerular staining of Ab Esel -liposomes was detected at 2h in 93±4%, at 1 day in 90±1%, and at 2 days in 81±6% of all glomeruli with approximately 10% of glomerular surface being positive for the specific immunoliposome (Fig. 4b) . Control
IgG-liposomes localized in glomeruli, likely due to local inflammation associated vascular permeability increase, but to a much lower extent (Fig 4a,b) . No Ab Eselliposomes localized in the heart, whereas some association of Ab Esel -liposomes was detected with cells in the red pulp in the spleen and with Kupffer cells in the liver, which reflects the regular elimination route of immunoliposomes in the body (data not shown).
To rule out the possibility that detecting the immunoliposomes using secondary antibody does not represent the liposomes themselves, we applied in a parallel Based on this selective homing to inflamed glomerular endothelium Ab Esel -liposomes were next employed as carriers for a targeted delivery of dexamethasone to interfere with glomerular endothelial cell activation and hence to counteract glomerulonephritis development and progression.
Targeted Dexamethasone Exerted Strong, Local Pharmacological Eeffects Without Alteration of Blood Glucose Level
Dexamethasone has pleiotropic anti-inflammatory effects, including an interaction with the transcription factors NF-κB and AP-1, thereby preventing expression of proinflammatory genes (Barnes, 2006) . We therefore compared the effects of PEGylated Ab Esel -liposomes encapsulated dexamethasone and free dexamethasone using mRNA levels of proinflammatory genes as read out. As expected, none of the treatments prevented depositions of sheep and mouse immunoglobulin in glomeruli (data not shown). Kidneys were harvested after 2h, a time point when proinflammatory genes were robustly upregulated. Free dexamethasone significantly inhibited gene expression induction of cell adhesion molecules and cytokines (Fig.   5a ). Targeted liposomal delivery of dexamethasone similarly resulted in significant downregulation of P-and E-selectin, whereas cytokine expression was slightly but not statistically significantly, affected. No effects on proinflammatory gene expression were observed in mice treated with empty Ab Esel -liposomes (Fig. 5a ).
Interestingly, expression of VCAM-1 was inhibited by free dexamethasone but not by cell selective delivery into glomerular endothelium. Based on our data on predominant non-glomerular expression of VCAM-1 (Fig. 3a) we hypothesized that This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 5b) . Similarly, glomerular expression of MCP1 was downregulated by Dexa-Ab Esel -liposomes, whereas no effect on MCP1 expression was observed in whole kidney isolates (Fig.   5 ). Downregulation of P-and E-selectin in microdissected glomeruli was comparable to that observed in whole kidney isolates (data not shown), corroborating the predominant expression of these cell adhesion molecules in glomeruli (Fig 3a) .
Dexamethasone is known to cause many side effects, such as osteoporosis, growth retardation in children, skin fragility and metabolic effects (Barnes, 2006) .
Hyperglycemia, caused by induction of hepatic gluconeogenesis and inhibition of cellular glucose uptake, is one of the most acute clinically relevant side effects of dexamethasone (Feldman-Billard et al., 2006; Hans et al., 2006; Weinstein et al., 1995) . Indeed, in mice treated with free dexamethasone the plasma glucose concentration 2h after i.v. injection of the drug was significantly increased (Fig. 6 ).
This was not observed in mice i.v. injected with dexamethasone encapsulated in immunoliposomes (Fig. 6) .
Treatment with Dexa-Ab Esel -liposomes Ameliorates Glomerulonephritis Progression
To study whether targeted inhibition of acute inflammatory gene expression in glomeruli would be able to counteract the occurrence of renal injury during glomerulonephritis development, mice were treated at day 0 and day 7 with free This article has not been copyedited and formatted. The final version may differ from this version. Plasma BUN levels in mice treated with Dexa-Ab Esel -liposomes were decreased as compared to levels in mice treated with Ab Esel -liposomes (Fig. 7a) . A similar reduction in BUN levels was observed in mice treated with free dexamethasone. A trend towards improved glomerular function exemplified by increased creatinine clearance was observed in both Dexa-Ab Esel -liposomes and dexamethasone treated mice (Fig. 7b) . Moreover, Dexa-Ab Esel -liposomes were able to strongly inhibit the formation of crescents in glomeruli (Fig. 7c,d ). The percentages of crescentic glomeruli decreased significantly from 30 ± 4% to 17 ± 4% (mean ± s.e.m.). Free dexamethasone showed a similar trend, however with a greater variation between mice (Fig. 7c) . Overall, renal injury was notably counteracted by treatment with Dexa-Ab Esel -liposomes, demonstrated by less glomerular lesions, intratubular protein casts, and tubulointerstitial damage (Fig. 7d) . Control Dexa-IgG-liposomes that did end up in the kidney to a 4-fold lower extent than targeted Dexa-Ab Esel -liposomes (see 
Discussion
In this study we demonstrate that targeted delivery of dexamethasone into glomerular endothelium by liposomes, modified with E-selectin specific monoclonal antibodies as homing device, selectively inhibited proinflammatory gene expression and improved renal function in progressive glomerulonephritis. Furthermore, the selective glomerular delivery of dexamethasone prevented unwanted systemic side effects which were observed after administration of free dexamethasone.
Anti-GBM crescentic glomerulonephritis can be treated with immunotherapy (Tam, 2006) . Nonetheless, the need for more specific therapies is evident. The functional redundancy of molecules involved in leukocyte-endothelial cell interactions, as well as the complexity of inflammatory gene expression control and protein function, justifies cell specific therapeutic intervention with a broad pharmacological spectrum (Rosenkranz and Mayadas, 1999; Kuldo et al., 2005) . Therefore we postulated that selective delivery of a potent anti-inflammatory drug with pleiotropic pharmacological effects into glomerular endothelium could exert a broad, yet local, inhibitory effect while preventing systemic side effects.
The current study is the first report describing a successful targeted delivery of drug loaded immunoliposomes to activated glomerular endothelial cells in glomerulonephritis in which local pharmacological activity did not interfere with vascular integrity. The local and disease specific expression of E-selectin on glomerular endothelium rendered it an excellent target molecule for drug delivery based therapy in glomerulonephritis. Previously, we reported a rapid receptor mediated internalization of anti E-selectin drug conjugates via E-selectin on activated endothelial cells (Kok et al., 2002; Asgeirsdottir et al., 2003; Everts et al., 2003) . This intracellular delivery allows endothelial cell specific pharmacological interference of This article has not been copyedited and formatted. The final version may differ from this version. The fact that elevated E-selectin expression has been detected in the kidney of patients with IgA nephropathy, lupus nephritis and diabetic nephropathy supports the clinical relevance of the development of E-selectin based drug targeting strategies (Honkanen et al., 1998; Hirata et al., 1998) . The use of endothelial target epitopes other than E-selectin can, however, be taken into account. Immunoliposomes directed toward VCAM-1 were internalized by activated endothelial cells in vitro (Voinea et al., 2005) , and in vivo demonstrated beneficial effects in an atherosclerosis mouse model (Homem de Bittencourt PI Jr et al., 2006) . The use of VCAM-1 selective immunoliposomes in glomerulonephritis to interfere with microvascular endothelial cells distinct from the glomerular capillaries is an attractive strategy, especially since VCAM-1 is highly expressed throughout disease progression (Allen et al., 1999) .
Laser capture microdissection is a valuable tool in (patho)physiology research as it, in combination with qRT-PCR, allows the detection of local disease activity that otherwise would be masked in analysis of a whole organ. For drug delivery research, microdissection is also instrumental in revealing local molecular targets of the therapeutic strategy studied. Using this approach we demonstrated that in our glomerulonephritis model upregulation of proinflammatory genes differed between the microvascular beds in the kidney. Strong upregulation of E-selectin was observed on glomerular endothelium, whereas VCAM-1 and MCP1 expression was mainly localized outside the glomeruli. Furthermore, RNA isolates of microdissected glomeruli revealed local downregulation of VCAM-1 and MCP1 by Dexa-Ab Eselliposomes, whereas the expression levels of these genes in whole kidney isolates were This article has not been copyedited and formatted. The final version may differ from this version. Targeted delivery to glomerular endothelium resulted in strong local pharmacological effects. In our study we used dexamethasone, a corticosteroid that is generally well tolerated after systemic administration, as a model drug to demonstrate proof of concept. However, today many potent anti inflammatory drugs do not make it through clinical trials because of severe side-effects (Peifer et al., 2006) . For these classes of drugs the targeted delivery approach described in this study represents an important added value for future clinical applications. The challenge for the future drug delivery will be to formulate new chemical entities that are rapidly being discovered and are currently making their ways into basic research and clinical trials. These new drugs include tyrosine kinase inhibitors, MAPKinase inhibitors, and other agents interfering with proinflammatory signal transduction pathways (Bergers et al., 2003; Karin, 2006; Fabian et al., 2005) . The recent observation that their molecular targets are fundamental in whole body homeostasis, makes their incorporation into cell-type specific drug delivery systems of essential value for clinical utility (Imming et al., 2006) .
We showed that Dexa-Ab Esel -liposomes were highly effective in improving renal Quantitative gene expression analysis of the cell adhesion molecules P-and Eselectin, VCAM-1, and ICAM-1, cytokines TNFα, IL-1β, IL-6, MCP1, and TGFβ in kidney of untreated mice (-), and at 2 h, and 1, 2, 7, and 14 days after induction of This article has not been copyedited and formatted. The final version may differ from this version. injected at days 0 and 7 of glomerulonephritis development with empty Ab Eselliposomes ( ), Dexa-Ab Esel -liposomes ( ) and free dexamethasone ( ). Gene expression was analyzed in whole kidney isolates at day 14. Expression levels of mRNA in healthy control mice ( ) were arbitrarily set at one.
